Thanks for the post 10-41.

Long and dense with scientific information for a non science guy like me to absorb but my take is that there are/will be millions of people globally that will need an anti-inflammatory like apabetalone to deal with the long term damage caused by covid.

Here is hoping that Brazil gets dosing soon, that we have a PR machine in place(Eversana???) to create high profile visibility and that clinicians see quick results and leak this information through their system and eventually the public. There are high concentrations of ealth in Brazil.

It's a lot to ask for, but always hopeful.

It is too bad that  the business side of RVX has not achieved a NASDAQ listing. The Covid trial would generate very high profile in the USA immediately. Oh well. The business side is just something we have to live with. Too bad.

GLTA

Toinv